DocDollars

Janssen Research & Development, LLC

NJ · United States · Reporting entity ID 100000005592

Total reported 2019–2025
$1.94B
#11 of 2,960 reporting companies — 2.3% of all reported industry payments
$29.2M in general payments across 11,085 records, plus $1.91B in research funding across 176,460 records.

How it breaks down

General payments $29,220,351
Research funding $1,910,533,737

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Janssen Research & Development, LLC reported $1.94B to US doctors and teaching hospitals from 2019 to 2025, ranking #11 of 2,960 reporting companies. 98% of that was research funding and 2% general payments such as consulting, speaking, food and travel. 11,085 general payment records and 176,460 research records were filed.

Common questions about Janssen Research & Development, LLC

How much has Janssen Research & Development, LLC paid US doctors?

Janssen Research & Development, LLC reported $1,939,754,087 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $29,220,351 in general payments, $1,910,533,737 in research funding.

How does Janssen Research & Development, LLC rank among drug and device companies?

It ranks #11 of 2,960 reporting entities by total reported value, about 2.3% of all industry payments in the dataset.

Does a payment from Janssen Research & Development, LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.